Q3 Earnings Estimate for Surgery Partners Issued By KeyCorp

Surgery Partners, Inc. (NASDAQ:SGRY) – Research analysts at KeyCorp dropped their Q3 2026 earnings estimates for shares of Surgery Partners in a report issued on Monday, October 26th. KeyCorp analyst M. Gillmor now anticipates that the company will post earnings per share of ($0.13) for the quarter, down from their prior forecast of ($0.12). The consensus estimate for Surgery Partners’ current full-year earnings is $0.25 per share. KeyCorp also issued estimates for Surgery Partners’ Q4 2026 earnings at ($0.08) EPS, FY2026 earnings at $0.07 EPS and FY2027 earnings at ($0.21) EPS.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Monday, August 10th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.04. The business had revenue of $848.90 million for the quarter, compared to analysts’ expectations of $830.03 million. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The company’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.17 EPS.

SGRY has been the subject of several other research reports. Zacks Research lowered Surgery Partners from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 10th. Benchmark reissued a “buy” rating on shares of Surgery Partners in a research report on Tuesday, August 11th. Cantor Fitzgerald cut Surgery Partners from an “overweight” rating to a “hold” rating in a research note on Monday, October 26th. Raymond James Financial set a $23.50 price objective on shares of Surgery Partners in a report on Monday, October 26th. Finally, UBS Group downgraded shares of Surgery Partners from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $21.00 to $23.50 in a report on Wednesday, October 28th. Four equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $20.14.

Surgery Partners Trading Down 0.4%

Shares of NASDAQ SGRY opened at $23.12 on Tuesday. The stock’s 50 day moving average price is $15.30 and its two-hundred day moving average price is $14.68. Surgery Partners has a 52-week low of $11.41 and a 52-week high of $23.37. The stock has a market capitalization of $3.03 billion, a P/E ratio of 116.20, a PEG ratio of 7.19 and a beta of 1.90. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18.

Insider Transactions at Surgery Partners

In other Surgery Partners news, Director Teresa DeLuca purchased 10,000 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was acquired at an average price of $14.35 per share, with a total value of $143,500.00. Following the acquisition, the director directly owned 66,843 shares of the company’s stock, valued at $959,197.05. This trade represents a 17.59% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 2.00% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Surgery Partners

Hedge funds have recently bought and sold shares of the business. Jupiter Topco LLC acquired a new stake in shares of Surgery Partners in the 2nd quarter valued at $233,220,000. Pentwater Capital Management LP acquired a new position in shares of Surgery Partners during the second quarter worth $195,384,000. BlackRock Inc. bought a new stake in shares of Surgery Partners in the second quarter worth $104,857,000. Dimensional Fund Advisors LP grew its stake in shares of Surgery Partners by 7.9% in the first quarter. Dimensional Fund Advisors LP now owns 5,296,411 shares of the company’s stock worth $63,131,000 after purchasing an additional 389,831 shares during the last quarter. Finally, Hsbc Holdings PLC acquired a new stake in Surgery Partners in the second quarter valued at $48,912,000.

Surgery Partners News Summary

Here are the key news stories impacting Surgery Partners this week:

• Positive Sentiment: Bon Secours Mercy Health’s proposed $23.50-per-share acquisition provides a clear valuation reference and supports the share price. Bain Capital, Surgery Partners’ largest shareholder, plans to roll its equity into the combined company, signaling substantial shareholder participation. Surgery Partners stock enters take-private focus after HealthSpan deal
• Neutral Sentiment: The consensus price target was raised 15.45% to $22.61, reflecting improved valuation expectations, but the target is below the merger offer and therefore provides limited incremental support while the transaction remains pending. Surgery Partners consensus price target increased by 15.45% to $22.61
• Negative Sentiment: KeyCorp reduced its FY2026 EPS forecast to $0.07 from $0.16 and cut its FY2027 forecast to a $0.21-per-share loss from expected earnings of $0.13. It also lowered its Q3 2026 estimate to a $0.13 loss, while forecasting a $0.08 loss for Q4. These revisions point to weaker near-term profitability than previously expected.
• Negative Sentiment: Multiple law firms are investigating the $23.50 merger, including whether Surgery Partners’ directors breached fiduciary duties and whether the transaction adequately serves shareholders. Such investigations may increase deal uncertainty, although these notices do not by themselves indicate that wrongdoing occurred. SGRY shareholder merger investigation Scott+Scott Surgery Partners investor alert

Surgery Partners Company Profile

Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.

Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.

Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.